MedTrace Logo

Association of Peripheral Immune Cells With Antidepressant Treatment Response

NCT06182722 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2024-04-09

No results posted yet for this study

Summary

The purpose of this observational study is discovering potential biomarkers to predict antidepressant treatment response in patients with major depressive disorder (MDD) while comparing the transcriptomic changes between patients with MDD and healthy controls as well as before and after antidepressant treatment.

Eligible patients will be assessed at Week 1, Week 2, Week 4 and Week 8 while healthy normal volunteers will only be evaluated at baseline. Assessments will include the following: an interview about mental and physical health, a physical examination including drawing of venous blood samples and several psychiatric rating scales.

Conditions

  • Depressive Disorder
  • Genetic Change

Interventions

DIAGNOSTIC_TEST

Mental assessments

Patients will receive psychiatric rating scales evaluation every visit.

Sponsors & Collaborators

  • Shanghai Mental Health Center

    lead OTHER

Principal Investigators

  • Shen He · Shanghai Mental Health Center

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-13
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06182722 on ClinicalTrials.gov